{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T09:16:09Z","timestamp":1784970969296,"version":"3.55.0"},"reference-count":101,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["General Hospital Psychiatry"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.genhosppsych.2025.08.013","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T15:50:55Z","timestamp":1756223455000},"page":"335-344","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["NMDA receptor-modulating treatments for cognitive deficits in patients with bipolar disorder: A narrative review"],"prefix":"10.1016","volume":"96","author":[{"given":"Rahim","family":"Badrfam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atefeh","family":"Zandifar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.genhosppsych.2025.08.013_bb0005","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1001\/jama.2023.18588","article-title":"Diagnosis and treatment of bipolar disorder: a review","volume":"330","author":"Nierenberg","year":"2023","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.08.013_bb0010","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41398-022-01917-x","article-title":"Neural network of bipolar disorder: toward integration of neuroimaging and neurocircuit-based treatment strategies","volume":"12","author":"Bi","year":"2022","journal-title":"Transl Psychiatry"},{"issue":"5","key":"10.1016\/j.genhosppsych.2025.08.013_bb0015","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1080\/14656566.2023.2194488","article-title":"An update on potential pharmacotherapies for cognitive impairment in bipolar disorder","volume":"24","author":"Johnson","year":"2023","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.genhosppsych.2025.08.013_bb0020","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1399-5618.2009.00716.x","article-title":"Identifying and treating cognitive impairment in bipolar disorder","volume":"11","author":"Goldberg","year":"2009","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.genhosppsych.2025.08.013_bb0025","article-title":"Cognitive impairment mechanism in patients with bipolar disorder","volume":"361-6","author":"Huang","year":"2023","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"5","key":"10.1016\/j.genhosppsych.2025.08.013_bb0030","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1159\/000324508","article-title":"Computerized testing of neurocognitive function in euthymic bipolar patients compared to those with mild cognitive impairment and cognitively healthy controls","volume":"80","author":"Osher","year":"2011","journal-title":"Psychother Psychosom"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.08.013_bb0035","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/bdi.12821","article-title":"Current understandings of the trajectory and emerging correlates of cognitive impairment in bipolar disorder: An overview of evidence","volume":"22","author":"Van Rheenen","year":"2020","journal-title":"Bipolar Disord"},{"issue":"11","key":"10.1016\/j.genhosppsych.2025.08.013_bb0040","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1017\/S0033291719001867","article-title":"Aberrant cognition in newly diagnosed patients with bipolar disorder and their unaffected relatives","volume":"50","author":"Kj\u00e6rstad","year":"2020","journal-title":"Psychol Med"},{"issue":"2","key":"10.1016\/j.genhosppsych.2025.08.013_bb0045","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/bdi.13163","article-title":"Deficits of social cognition in bipolar disorder: systematic review and meta-analysis","volume":"24","author":"Gillissie","year":"2022","journal-title":"Bipolar Disord"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.08.013_bb0050","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/19585969.2022.2042164","article-title":"Neurocognitive functioning in bipolar disorder: what we know and what we don\u2019t","volume":"23","author":"Keramatian","year":"2021","journal-title":"Dialogues Clin Neurosci"},{"issue":"12","key":"10.1016\/j.genhosppsych.2025.08.013_bb0055","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.2174\/1570159X20666220706110157","article-title":"Bipolar disorder and manic-like symptoms in Alzheimer\u2019s, vascular and frontotemporal dementia: a systematic review","volume":"21","author":"Elefante","year":"2023","journal-title":"Curr Neuropharmacol"},{"issue":"3","key":"10.1016\/j.genhosppsych.2025.08.013_bb0060","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/bdi.12848","article-title":"Cognitive enhancement interventions for people with bipolar disorder: a systematic review of methodological quality, treatment approaches, and outcomes","volume":"22","author":"Tsapekos","year":"2020","journal-title":"Bipolar Disord"},{"issue":"6","key":"10.1016\/j.genhosppsych.2025.08.013_bb0065","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/s41386-020-00901-7","article-title":"Change in prefrontal activity and executive functions after action-based cognitive remediation in bipolar disorder: a randomized controlled trial","volume":"46","author":"Ott","year":"2021","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.genhosppsych.2025.08.013_bb0070","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/bdi.13175","article-title":"Cognition in older adults with bipolar disorder: an ISBD task force systematic review and meta-analysis based on a comprehensive neuropsychological assessment","volume":"24","author":"Montejo","year":"2022","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.genhosppsych.2025.08.013_bb0075","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.euroneuro.2022.11.004","article-title":"The trajectory of emotional and non-emotional cognitive function in newly diagnosed patients with bipolar disorder and their unaffected relatives: a 16-month follow-up study","volume":"67","author":"Kj\u00e6rstad","year":"2023","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.genhosppsych.2025.08.013_bb0080","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.neubiorev.2014.08.017","article-title":"The role of NMDA receptors in the pathophysiology and treatment of mood disorders","volume":"47","author":"Ghasemi","year":"2014","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.genhosppsych.2025.08.013_bb0085","series-title":"Glutamate and neuropsychiatric disorders: current and emerging treatments","first-page":"261","article-title":"The glutamatergic system as a target for the development of new pharmacological treatments of bipolar disorder","author":"Karakatsoulis","year":"2022"},{"key":"10.1016\/j.genhosppsych.2025.08.013_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101838","article-title":"Glutamatergic neurotransmission: a potential pharmacotherapeutic target for the treatment of cognitive disorders","volume":"85","author":"Chakraborty","year":"2023","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.genhosppsych.2025.08.013_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2024.115173","article-title":"Targeting NMDA receptors with an antagonist is a promising therapeutic strategy for treating neurological disorders","volume":"472","author":"Rafe","year":"2024","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.genhosppsych.2025.08.013_bb0100","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neuropharm.2012.06.051","article-title":"The NMDA receptor as a target for cognitive enhancement","volume":"64","author":"Collingridge","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.genhosppsych.2025.08.013_bb0105","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.neubiorev.2017.07.002","article-title":"Mechanisms of action and clinical efficacy of NMDA receptor modulators in mood disorders","volume":"80","author":"Ghasemi","year":"2017","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.genhosppsych.2025.08.013_bb0110","first-page":"381","article-title":"Diagnosis and management of bipolar disorders","author":"Goes","year":"2023","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.genhosppsych.2025.08.013_bb0115","first-page":"399","article-title":"Management of cognitive impairment in bipolar disorder: a systematic review of randomized controlled trials","volume":"27","author":"Tamura","year":"2022","journal-title":"CNS Spectr"},{"key":"10.1016\/j.genhosppsych.2025.08.013_bb0120","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jad.2020.11.001","article-title":"Role of rTMS in the treatment of cognitive impairments in bipolar disorder and schizophrenia: a review of randomized controlled trials","volume":"280","author":"Sciortino","year":"2021","journal-title":"J Affect Disord"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.08.013_bb0125","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s40263-019-00688-2","article-title":"Cognitive impairment in patients with bipolar disorder: impact of pharmacological treatment","volume":"34","author":"Xu","year":"2020","journal-title":"CNS Drugs"},{"key":"10.1016\/j.genhosppsych.2025.08.013_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104906","article-title":"The neuroprotective and neuroplastic potential of glutamatergic therapeutic drugs in bipolar disorder","volume":"142","author":"Guglielmo","year":"2022","journal-title":"Neurosci Biobehav Rev"},{"issue":"10","key":"10.1016\/j.genhosppsych.2025.08.013_bb0135","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1080\/13543776.2020.1811234","article-title":"N-methyl-D-aspartate (NMDA) receptor modulators: a patent review (2015-present)","volume":"30","author":"Ahmed","year":"2020","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.genhosppsych.2025.08.013_bb0140","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jpsychires.2021.10.037","article-title":"The potential pro-cognitive effects with intravenous subanesthetic ketamine in adults with treatment-resistant major depressive or bipolar disorders and suicidality","volume":"144","author":"Zhou","year":"2021","journal-title":"J Psychiatr Res"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.08.013_bb0145","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.schres.2011.10.015","article-title":"The MATRICS consensus cognitive battery (MCCB): clinical and cognitive correlates","volume":"134","author":"August","year":"2012","journal-title":"Schizophr Res"},{"key":"10.1016\/j.genhosppsych.2025.08.013_bb0150","article-title":"Cognitive function mediates the anti-suicide effect of repeated intravenous ketamine in adult patients with suicidal ideation","volume":"13","author":"Zhou","year":"2022","journal-title":"Front Psychol"},{"issue":"9","key":"10.1016\/j.genhosppsych.2025.08.013_bb0155","doi-asserted-by":"crossref","first-page":"S246","DOI":"10.1016\/j.biopsych.2020.02.638","article-title":"Add-on memantine may improve cognition and attenuate inflammatory status in middle-to-old aged bipolar II disorder patients","volume":"87","author":"Wang","year":"2020","journal-title":"Biol Psychiatry"},{"issue":"224","key":"10.1016\/j.genhosppsych.2025.08.013_bb0160","first-page":"17","article-title":"Effect of memantine on cognitive performance of patients with mood disorders under electroconvulsive therapy: a triple-blind clinical trial","volume":"33","author":"Hamidia","year":"2023","journal-title":"J Mazandaran Univ Med Sci"},{"issue":"4","key":"10.1016\/j.genhosppsych.2025.08.013_bb0165","doi-asserted-by":"crossref","first-page":"421","DOI":"10.4306\/pi.2013.10.4.421","article-title":"A 10-week memantine treatment in bipolar depression: a case report. Focus on depressive symptomatology, cognitive parameters and quality of life","volume":"10","author":"Strzelecki","year":"2013","journal-title":"Psychiatry Investig"},{"issue":"5","key":"10.1016\/j.genhosppsych.2025.08.013_bb0170","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/PRA.0000000000000576","article-title":"Improvement in memory deficits with memantine in mania secondary to traumatic brain injury and preexisting perinatal birth injury","volume":"27","author":"Das","year":"2021","journal-title":"J Psychiatr Pract"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.08.013_bb0175","doi-asserted-by":"crossref","first-page":"148","DOI":"10.4103\/abr.abr_110_18","article-title":"Evaluation of the effect of memantine supplementation in the treatment of acute phase of mania in bipolar disorder of elderly patients: a double-blind randomized controlled trial","volume":"7","author":"Omranifard","year":"2018","journal-title":"Adv Biomed Res"},{"issue":"12","key":"10.1016\/j.genhosppsych.2025.08.013_bb0180","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.3390\/jcm11123344","article-title":"The need for a specialized neurocognitive screen and consistent cognitive impairment criteria in spinal cord injury: analysis of the suitability of the neuropsychiatry unit cognitive assessment tool","volume":"11","author":"Sandalic","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.genhosppsych.2025.08.013_bb0185","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.euroneuro.2024.04.014","article-title":"Ketamine treatment for anhedonia in unipolar and bipolar depression: a systematic review","volume":"86","author":"Kwa\u015bny","year":"2024","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.genhosppsych.2025.08.013_bb0190","article-title":"Ketamine\u2013an imperfect wonder drug?","volume":"116516","author":"Magruder","year":"2024","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.08.013_bb0195","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1146\/annurev-med-051322-120608","article-title":"Ketamine: mechanisms and relevance to treatment of depression","volume":"75","author":"Kim","year":"2024","journal-title":"Annu Rev Med"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.08.013_bb0200","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41386-023-01632-1","article-title":"Ketamine in neuropsychiatric disorders: an update","volume":"49","author":"Johnston","year":"2024","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.08.013_bb0205","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41386-023-01629-w","article-title":"Ketamine and rapid antidepressant action: new treatments and novel synaptic signaling mechanisms","volume":"49","author":"Krystal","year":"2024","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"10.1016\/j.genhosppsych.2025.08.013_bb0210","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1038\/s41591-024-03063-x","article-title":"Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial","volume":"30","author":"Glue","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.genhosppsych.2025.08.013_bb0215","doi-asserted-by":"crossref","first-page":"1337749","DOI":"10.3389\/fphar.2024.1337749","article-title":"Exploring the multifaceted potential of (R)-ketamine beyond antidepressant applications","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Pharmacol"},{"issue":"7","key":"10.1016\/j.genhosppsych.2025.08.013_bb0220","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/ijnp\/pyab023","article-title":"Ketamine for bipolar depression: a systematic review","volume":"24","author":"Bahji","year":"2021","journal-title":"Int J Neuropsychopharmacol"},{"issue":"4","key":"10.1016\/j.genhosppsych.2025.08.013_bb0225","doi-asserted-by":"crossref","first-page":"57118","DOI":"10.4088\/JCP.24m15376","article-title":"Efficacy and safety of ketamine\/Esketamine in bipolar depression in a clinical setting","volume":"85","author":"Santucci","year":"2024","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.08.013_bb0230","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/JCP.0000000000001317","article-title":"A systematic review on the efficacy of intravenous racemic ketamine for bipolar depression","volume":"41","author":"Joseph","year":"2021","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.genhosppsych.2025.08.013_bb0235","first-page":"1325399","article-title":"Efficacy and safety of ketamine and esketamine for unipolar and bipolar depression: an overview of systematic reviews with meta-analysis","volume":"15","author":"Rodolico","year":"2024","journal-title":"Front Psychol"},{"key":"10.1016\/j.genhosppsych.2025.08.013_bb0240","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.jad.2020.07.119","article-title":"Neurocognitive impact of ketamine treatment in major depressive disorder: a review on human and animal studies","volume":"276","author":"Crisanti","year":"2020","journal-title":"J Affect Disord"},{"key":"10.1016\/j.genhosppsych.2025.08.013_bb0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jpsychires.2022.12.010","article-title":"Subanesthetic dose of S-ketamine improved cognitive dysfunction via the inhibition of hippocampal astrocytosis in a mouse model of post-stroke chronic stress","volume":"158","author":"Zhang","year":"2023","journal-title":"J Psychiatr Res"},{"issue":"4","key":"10.1016\/j.genhosppsych.2025.08.013_bb0250","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s00213-023-06514-4","article-title":"Ketamine produces no detectable long-term positive or negative effects on cognitive flexibility or reinforcement learning of male rats","volume":"241","author":"Nist","year":"2024","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.08.013_bb0255","doi-asserted-by":"crossref","first-page":"38984","DOI":"10.4088\/JCP.21r13870","article-title":"The effects of ketamine on cognition in unipolar and bipolar depression: a systematic review","volume":"83","author":"Vaccarino","year":"2022","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.genhosppsych.2025.08.013_bb0260","doi-asserted-by":"crossref","first-page":"111095","DOI":"10.1016\/j.pnpbp.2024.111095","article-title":"Cognitive changes in patients with unipolar TRD treated with IV ketamine: a systematic review","volume":"135","author":"Grasso","year":"2024","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.genhosppsych.2025.08.013_bb0265","first-page":"62","article-title":"Ketamine for the treatment of major depression: a systematic review and meta-analysis","author":"Nikolin","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.genhosppsych.2025.08.013_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.actpsy.2022.103563","article-title":"Verbal learning, working memory, and attention\/vigilance may be candidate phenotypes of bipolar II depression in Chinese Han nationality","volume":"226","author":"Hu","year":"2022","journal-title":"Acta Psychol"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.08.013_bb0275","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jad.2012.02.028","article-title":"Is processing speed a valid cognitive endophenotype for bipolar disorder?","volume":"139","author":"Daban","year":"2012","journal-title":"J Affect Disord"},{"key":"10.1016\/j.genhosppsych.2025.08.013_bb0280","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.euroneuro.2020.04.006","article-title":"Cognitive modelling to assess decision-making impairments in patients with current depression and with\/without suicide history","volume":"36","author":"Alacreu-Crespo","year":"2020","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.genhosppsych.2025.08.013_bb0285","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s11739-010-0355-z","article-title":"The uncontrolled clinical trial: scientific, ethical, and practical reasons for being","volume":"5","author":"Sacc\u00e0","year":"2010","journal-title":"Intern Emerg Med"},{"issue":"3","key":"10.1016\/j.genhosppsych.2025.08.013_bb0290","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/ibra.12098","article-title":"Basic information about memantine and its treatment of Alzheimer\u2019s disease and other clinical applications","volume":"9","author":"Tang","year":"2023","journal-title":"Ibrain"},{"key":"10.1016\/j.genhosppsych.2025.08.013_bb0295","series-title":"StatPearls [Internet]","author":"Kuns","year":"2024"},{"key":"10.1016\/j.genhosppsych.2025.08.013_bb0300","article-title":"Memantine: updating a rare success story in pro-cognitive therapeutics","volume":"244","author":"Tari","year":"2024","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.08.013_bb0305","doi-asserted-by":"crossref","first-page":"20969","DOI":"10.4088\/JCP.13m08956","article-title":"Three-year, naturalistic, mirror-image assessment of adding memantine to the treatment of 30 treatment-resistant patients with bipolar disorder","volume":"76","author":"Serra","year":"2015","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.genhosppsych.2025.08.013_bb0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40345-019-0174-8","article-title":"Combination of dextromethorphan and memantine in treating bipolar spectrum disorder: a 12-week double-blind randomized clinical trial","volume":"8","author":"Lee","year":"2020","journal-title":"Int J Bipolar Disord"},{"issue":"9","key":"10.1016\/j.genhosppsych.2025.08.013_bb0315","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.3390\/jpm13091395","article-title":"Associations of BDNF\/BDNF-AS SNPs with depression, schizophrenia, and bipolar disorder","volume":"13","author":"Shkundin","year":"2023","journal-title":"J Personal Med"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.08.013_bb0320","first-page":"32","article-title":"Inflammatory biomarkers, cognitive functioning, and brain imaging abnormalities in bipolar disorder: a systematic review","volume":"21","author":"Mario","year":"2024","journal-title":"Clin Neuropsychiatry"},{"key":"10.1016\/j.genhosppsych.2025.08.013_bb0325","article-title":"Memantine can protect against inflammation-based cognitive decline in geriatric depression","volume":"9","author":"Van Dyk","year":"2020","journal-title":"Brain Behav Immun Health"},{"issue":"3","key":"10.1016\/j.genhosppsych.2025.08.013_bb0330","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/arclin\/acu006","article-title":"Convergent validity of the integrated visual and auditory continuous performance test (IVA+ plus): associations with working memory, processing speed, and behavioral ratings","volume":"29","author":"Arble","year":"2014","journal-title":"Arch Clin Neuropsychol"},{"key":"10.1016\/j.genhosppsych.2025.08.013_bb0335","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jad.2022.03.047","article-title":"The efficacy and tolerability of memantine for depressive symptoms in major mental diseases: a systematic review and updated meta-analysis of double-blind randomized controlled trials","volume":"306","author":"Hsu","year":"2022","journal-title":"J Affect Disord"},{"issue":"19","key":"10.1016\/j.genhosppsych.2025.08.013_bb0340","article-title":"Neuroprotective effects of amantadine for experimental acute carbon monoxide poisoning","volume":"26","author":"Zengin","year":"2022","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.genhosppsych.2025.08.013_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2021.113443","article-title":"Involvement of dopamine D2 and glutamate NMDA receptors in the antidepressant-like effect of amantadine in mice","volume":"413","author":"Raupp-Barcaro","year":"2021","journal-title":"Behav Brain Res"},{"issue":"12","key":"10.1016\/j.genhosppsych.2025.08.013_bb0350","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1474-4422(21)00249-0","article-title":"Amantadine in the treatment of Parkinson\u2019s disease and other movement disorders","volume":"20","author":"Rascol","year":"2021","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.08.013_bb0355","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3109\/10253890.2015.1108302","article-title":"Antidepressant-like effects and possible mechanisms of amantadine on cognitive and synaptic deficits in a rat model of chronic stress","volume":"19","author":"Yu","year":"2016","journal-title":"Stress"},{"key":"10.1016\/j.genhosppsych.2025.08.013_bb0360","article-title":"The effect of amantadine on recovery, postoperative cognitive dysfunction and pain after Propofol anesthesia in mice","volume":"115290","author":"Alacam","year":"2024","journal-title":"Behav Brain Res"},{"issue":"7","key":"10.1016\/j.genhosppsych.2025.08.013_bb0365","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.3390\/biomedicines12071558","article-title":"Amantadine for traumatic brain injury\u2014supporting evidence and mode of action","volume":"12","author":"Dekundy","year":"2024","journal-title":"Biomedicines"},{"issue":"10","key":"10.1016\/j.genhosppsych.2025.08.013_bb0370","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3390\/ph13100326","article-title":"Possibility of a new indication for amantadine in the treatment of bipolar depression\u2014case series study","volume":"13","author":"Krzystanek","year":"2020","journal-title":"Pharmaceuticals"},{"issue":"5","key":"10.1016\/j.genhosppsych.2025.08.013_bb0375","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/ijo.2021.5275","article-title":"Riluzole: a neuroprotective drug with potential as a novel anti-cancer agent","volume":"59","author":"Blyufer","year":"2021","journal-title":"Int J Oncol"},{"issue":"12","key":"10.1016\/j.genhosppsych.2025.08.013_bb0380","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1093\/brain\/awab222","article-title":"Riluzole, a glutamate modulator, slows cerebral glucose metabolism decline in patients with Alzheimer\u2019s disease","volume":"144","author":"Matthews","year":"2021","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.genhosppsych.2025.08.013_bb0385","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.pbb.2011.09.010","article-title":"Novel glutamatergic agents for major depressive disorder and bipolar disorder","volume":"100","author":"Machado-Vieira","year":"2012","journal-title":"Pharmacol Biochem Behav"},{"issue":"9","key":"10.1016\/j.genhosppsych.2025.08.013_bb0390","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1517\/17425255.4.9.1223","article-title":"Riluzole in psychiatry: a systematic review of the literature","volume":"4","author":"Zarate","year":"2008","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"1\u20134","key":"10.1016\/j.genhosppsych.2025.08.013_bb0395","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000529534","article-title":"Prophylactic efficacy of riluzole against anxiety-and depressive-like behaviors in two rodent stress models","volume":"9","author":"Bansal","year":"2023","journal-title":"Complex Psychiatry"},{"issue":"3","key":"10.1016\/j.genhosppsych.2025.08.013_bb0400","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/npp.2009.191","article-title":"Rapid enhancement of glutamatergic neurotransmission in bipolar depression following treatment with riluzole","volume":"35","author":"Brennan","year":"2010","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.genhosppsych.2025.08.013_bb0405","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.biopsych.2004.11.023","article-title":"An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depression","volume":"57","author":"Zarate","year":"2005","journal-title":"Biol Psychiatry"},{"issue":"3","key":"10.1016\/j.genhosppsych.2025.08.013_bb0410","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/JCP.0000000000000693","article-title":"A double-blind, placebo-controlled, pilot study of riluzole monotherapy for acute bipolar depression","volume":"37","author":"Park","year":"2017","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.genhosppsych.2025.08.013_bb0415","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.neuropharm.2019.02.023","article-title":"Treatment with the glutamate modulator riluzole prevents early life stress-induced cognitive deficits and impairments in synaptic plasticity in APPswe\/PS1dE9 mice","volume":"150","author":"Lesuis","year":"2019","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.genhosppsych.2025.08.013_bb0420","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/mp.2016.33","article-title":"Age and Alzheimer\u2019s disease gene expression profiles reversed by the glutamate modulator riluzole","volume":"22","author":"Pereira","year":"2017","journal-title":"Mol Psychiatry"},{"issue":"2","key":"10.1016\/j.genhosppsych.2025.08.013_bb0425","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/fcp.12955","article-title":"Neuroprotective effects of riluzole in Alzheimer\u2019s disease: a comprehensive review","volume":"38","author":"Golmohammadi","year":"2024","journal-title":"Fundam Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.genhosppsych.2025.08.013_bb0430","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1080\/00325481.2022.2035092","article-title":"Management of pain using magnesium sulphate: a narrative review","volume":"134","author":"Soleimanpour","year":"2022","journal-title":"Postgrad Med"},{"issue":"10","key":"10.1016\/j.genhosppsych.2025.08.013_bb0435","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1113\/JP284381","article-title":"Magnesium sulphate reduces tertiary gliosis but does not improve EEG recovery or white or grey matter cell survival after asphyxia in preterm fetal sheep","volume":"601","author":"Galinsky","year":"2023","journal-title":"J Physiol"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.08.013_bb0440","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s41043-023-00423-0","article-title":"A narrative review on the role of magnesium in immune regulation, inflammation, infectious diseases, and cancer","volume":"42","author":"Ashique","year":"2023","journal-title":"J Health Popul Nutr"},{"key":"10.1016\/j.genhosppsych.2025.08.013_bb0445","series-title":"Effect of magnesium sulphate for antenatal mothers in preterm labour for neuroprotection in infants","author":"Jayashree","year":"2025"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.08.013_bb0450","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s12011-021-02619-z","article-title":"Effects of a novel magnesium complex on metabolic and cognitive functions and the expression of synapse-associated proteins in rats fed a high-fat diet","volume":"200","author":"Orhan","year":"2022","journal-title":"Biol Trace Elem Res"},{"key":"10.1016\/j.genhosppsych.2025.08.013_bb0455","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.799824","article-title":"Association of circulating magnesium levels in patients with Alzheimer\u2019s disease from 1991 to 2021: a systematic review and meta-analysis","volume":"13","author":"Du","year":"2022","journal-title":"Front Aging Neurosci"},{"issue":"19","key":"10.1016\/j.genhosppsych.2025.08.013_bb0460","doi-asserted-by":"crossref","first-page":"8423","DOI":"10.1523\/JNEUROSCI.4610-12.2013","article-title":"Elevation of brain magnesium prevents and reverses cognitive deficits and synaptic loss in Alzheimer\u2019s disease mouse model","volume":"33","author":"Li","year":"2013","journal-title":"Soc Neurosci"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.08.013_bb0465","doi-asserted-by":"crossref","first-page":"1","DOI":"10.13005\/bpj\/2582","article-title":"Magnesium and zinc in bipolar disorders","volume":"16","author":"Nechifor","year":"2023","journal-title":"Biomed Pharmacol J"},{"key":"10.1016\/j.genhosppsych.2025.08.013_bb0470","series-title":"Magnesium in psychoses (schizophrenia and bipolar disorders)","author":"Nechifor","year":"2018"},{"issue":"1","key":"10.1016\/j.genhosppsych.2025.08.013_bb0475","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000341309","article-title":"Nutrient-based therapies for bipolar disorder: a systematic review","volume":"82","author":"Sylvia","year":"2012","journal-title":"Psychother Psychosom"},{"issue":"12","key":"10.1016\/j.genhosppsych.2025.08.013_bb0480","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1021\/acschemneuro.3c00088","article-title":"Classics in chemical neuroscience: dextromethorphan (DXM)","volume":"14","author":"McClure","year":"2023","journal-title":"ACS Chem Neurosci"},{"issue":"2","key":"10.1016\/j.genhosppsych.2025.08.013_bb0485","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1080\/03602532.2020.1758712","article-title":"Pharmacokinetics and pharmacodynamics of dextromethorphan: clinical and forensic aspects","volume":"52","author":"Silva","year":"2020","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.genhosppsych.2025.08.013_bb0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2020.173003","article-title":"Assessment of the rapid and sustained antidepressant-like effects of dextromethorphan in mice","volume":"197","author":"Saavedra","year":"2020","journal-title":"Pharmacol Biochem Behav"},{"issue":"3","key":"10.1016\/j.genhosppsych.2025.08.013_bb0495","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/14737175.2023.2192402","article-title":"Combinations of dextromethorphan for the treatment of mood disorders-a review of the evidence","volume":"23","author":"Parincu","year":"2023","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.genhosppsych.2025.08.013_bb0500","doi-asserted-by":"crossref","DOI":"10.1177\/15333175221124952","article-title":"The association between dextromethorphan use and the risk of dementia","volume":"37","author":"Chen","year":"2022","journal-title":"Am J Alzheimers Dis Other Dement"},{"key":"10.1016\/j.genhosppsych.2025.08.013_bb0505","article-title":"Repeated dextromethorphan administration in adolescent rats produces long-lasting behavioral alterations","volume":"227","author":"Bates","year":"2023","journal-title":"Pharmacol Biochem Behav"}],"container-title":["General Hospital Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834325001690?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834325001690?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T12:41:06Z","timestamp":1757335266000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163834325001690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":101,"alternative-id":["S0163834325001690"],"URL":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2025.08.013","relation":{},"ISSN":["0163-8343"],"issn-type":[{"value":"0163-8343","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NMDA receptor-modulating treatments for cognitive deficits in patients with bipolar disorder: A narrative review","name":"articletitle","label":"Article Title"},{"value":"General Hospital Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2025.08.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}